Meilleures pratiques - Traitement d'entretien à la méthadone

Liste de références et lectures additionnelles suggérées

• Abbott, P.J., Moore, B.A., Weller, S.B, et Delaney, H.D. (1998). AIDS risk behaviour in opioid-dependent patients treated with Community Reinforcement Approach and relationships with psychiatric disorders. Journal of Addictive Diseases, 17 (4), 33-48.
  
  
• Addiction Research Foundation. (n.d.). Methadone maintenance therapy: Information for clients. Toronto: Author (now Centre for Addiction and Mental Health).
  
  
• Albert, T., Williams, G., Legowski, B., et Remis, R.(1998). The economic burden of HIV/AIDS in Canada. Ottawa: Canadian Policy Research Networks (CPRN).
  
  
• Archibald, C. (1997). Overview of HIV infection among injection drug users. Canadian AIDS News, [On-line] 9 (4), 1-3.
  

• Belding, M.A., McLellan, T., Zanis, D.A., et Incmikosk, R.(1998). Characterizing "nonresponsive" methadone patients. Journal of Substance Abuse Treatment, 15 (6), 485-492.
  

• Bell, J. (1998a). Delivering effective methadone treatment. In J. Ward, R. P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 161-175). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  

• Bell, J. (1998b). Staff training in methadone clinics. In J. Ward, R.P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 361-377). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  

• Best, D., Glossop, M., Greenwood, J., Marsden, J., Lehman, P., et Strung, J. (1999). Cannabis use in relation to illicit drug use and health problems among opiate misusers in treatment. Drug et Alcohol Review, 18, 31-38.
  

• Best, D., Lehmann, P., Glossop, M., Harris, J., Noble, A., et Strung, J. (1998). Eating too little, smoking and drinking too much: Wider lifestyle problems among methadone maintenance patients. Addiction Research, 00, 1-10.
  

• Brands, B., et Brands, J. (Eds.).(1998). Methadone Maintenance: A Physician's Guide to Treatment. Toronto: Addiction Research Foundation, Centre for Addiction and Mental Health.
  
  
• Brands, J., Brands, B., et Marsh D. (2000). The expansion of methadone prescribing in Ontario, 1996-1998. Addiction Research, 1(5), 485-496.
  
  
• Brands, B., Kahan, M., Selby, P., et Wilson, L. (Eds.). (2000). Management of alcohol, tobacco and other drug problems. Toronto: Centre for Addiction and Mental Health.
  
  
• Brands, J., et Janecek, E. (Eds.). (2000). Methadone maintenance: A pharmacist's guide to treatment. Toronto: Centre for Addiction and Mental Health.
  
  
• Brands, B., Sproule, B., et Marshmer, J. (Eds.).(1998). Drugs and drug abuse: A reference text. (3^rd ed.). Toronto: Addiction Research Foundation, Centre for Addiction and Mental Health.
  
  
• Broers, B., Junet, C., Bourquin, M., Déglon, J.J., Perrin, L., et Hirschel, B. (1998). Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS, 12(15), 2059-2066.
  
  
• Broome, K.M., Simpson, D.D., et Joe, G.W. (1999). Patient and program attributes related to treatment process indicators in DATOS. Drug and Alcohol Dependence, 57, 127-135.
  
  
• Brown, H.L., Britton, K.A., Mahaffey, D., Brizendine, E., Hiett, K., et Turnquest, M.A.(1998). Methadone maintenance in pregnancy: A reappraisal. American Journal of Obstetrics and Gynecology, 179 (2), 459-463.
  
  
• Budney, A. J., Bickel, W. K., et Amass, L. (1998). Marijuana use and treatment outcome among opioid-dependent patients. Addiction, 93(4), 493-503
  
  
• Canadian Association for Study of the Liver (CASL) Consensus Conference Rapporteur Group. (2000). Canadian Consensus Conference on the Management of Viral Hepatitis. Canadian Journal of Gastroenterology 14 (Supplement B Current Issues in the Management of Viral Hepatitis), 5B-20B.
  
  
• Canadian Centre on Substance Abuse and Canadian Public Health Association. (1997). HIV/AIDS and injection drug use: A national action plan. Ottawa: Authors.

• Canadian Centre on Substance Abuse and Centre for Addiction and MentalHealth.(1999). Canadian profile: Alcohol, tobacco and other drugs 1999. Ottawa and Toronto: Authors
  
  
• Canadian HIV-AIDS Legal Network. (1999). Injection drug use and HIV/AIDS: Legal and ethical issues. Montreal: Author.
  

• Canadian HIV/AIDS Legal Network and Canadian AIDS Society. (1996). HIV/AIDS in prisons: Final report. Prepared by Ralf Jurgens. Montreal: Authors.
  
  
• Caplehorn, J. R. M., Lumley, T. S., et Irwig, L. (1998). Staff attitudes and retention of patients in methadone maintenance programs. Drug and Alcohol Abuse, 52  (1), 57-61.
  

• Correctional Service Canada. (October 1998). National Methadone Maintenance Treatment Program Phase 1: Resource and Information Package.
  
  
• Crofts, N., Nigro, L., Oman, K., Stevenson, E., et Sherman, J. (1997). Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction, 92 (8), 999-1005.
  

• Darke, S. (1998a). Self-report among injecting drug users: A review. Drug and Alcohol Dependence, 51(3), 253-263
  
  
• Darke, S. (1998b). The effectiveness of methadone maintenance treatment 3: Moderators of treatment outcome. In J. Ward, R. P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 75-89). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  

• Darke, S., Kaye, S., et Finlay-Jones, R. (1998). Antisocial personality disorder, psychopathy and injecting heroin use. Drug and Alcohol Dependence, 52, 63-69.
  
  
• Darke, S., Hall, W., Swift, W. (1994). Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients. Drug and Alcohol Dependence, 34, 253-257.
  
  
• Dazord, A., Mino, A., Page, D., et Broers, B. (1998). Patients on methadone maintenance treatment in Geneva. Eur Psychiatry, 13, 235-241.
  
  
• D'Ippoliti, D., Davoli, M., Perucci, C. A., Pasqualini, F., et Bargagli, A. M. (1998).
  
  
• Retention in treatment of heroin users in Italy: The role of treatment type and of methadone maintenance dosage. Drug and Alcohol Dependence, 52(2), 167-171.
  
  
• Dolan, K., Hall, W., et Wodak, A. (1998). The provision of methadone in prison settings. In J. Ward, R. P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 379-396). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• DSM IV, Manuel diagnostique et statistique des troubles mentaux. Éditions Masson, Paris, 1996.
  

• Fingerhood, M .I. (1999). Comorbid medical disorders. In E. C. Strain et M. L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 118-140). Baltimore: The Johns Hopkins University Press.
  

• Finnegan, L.P. (1991). Treatment issues for opioid-dependent women during the prenatal period. Journal of Psychoactive Drugs, 23 (2), 191-201.
  
  
• Fischer, B., et Rehm, J. (1997). The case for a heroin substitution treatment trial in Canada. Canadian Journal of Public Health, 88(6), 367-370.
  
  
• Fletcher, B.W., et Battjes, R.J. (1999). Introduction to the special issue: treatment process in DATOS. Drug and Alcohol Dependence, 57, 81-87.
  
  
• Gaughwin, M., Solomon, P., et Ali, R. (1998). Correlates of retention on the South Australian Methadone Program, 1981-1991. Australian and New Zealand Journal of Public Health, 22 (7), 771-776.
  
  
• Gilbert, L., El-Bassel, N., Rajah, V., Foleno, A., Fontdevila, J, Frye, V., et Richmand, B.L. (2000). The converging epidemics of mood-altering-drug use, HIV, HCV, and partner violence. The Mount Sinai Journal of Medicine, 67 (5et6), 452-463.
  
  
• Glezen, L. A., et Lowery, C. A. (1999). Practical issues of program organization and operation. In E. C. Strain et M. L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 223-249). Baltimore: The Johns Hopkins University Press.
  
  
• Gourevitch, M.N., et Friedland, G.H. (2000). Interactions between methadone and medications used to treat HIV infection: A review. The Mount Sinai Journal of Medicine, 67 (5et6), 429-436.
  
  
• Hagan, H., et Des Jarlais, D.C. (2000). HIV and HCV infection among injecting drug users. The Mount Sinai Journal of Medicine, 67 (5 et 6), 423-428.
  
  
• Hall, W., Ward, J., et Mattick, R. P. (1998a). Introduction. In J. Ward, R. P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 1-14). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Hall W., Ward, J., et Mattick, R. P. (1998b). The effectiveness of methadone maintenance treatment 1: Heroin use and crime. In J. Ward, R.P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 17-57). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  

• Hankins, C. A. (1998). Syringe exchange in Canada: Good but not enough to stem the HIV tide. Substance Use and Misuse, 33(5), 1129-1146.
  

• Hartel, D.M., et E.E. Schoenbaum. (1998). Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City. Public Health Reports, 113 (Supplement 1), 107-115.
  
  
• Jarvis, M.A.E., et Schnoll, S.H. (1994). Methadone treatment during pregnancy. Journal of Psychoactive Drugs, 26 (2), 155-161.
  

• Jarvis, M., et coll. (1999). Alterations in methadone maintenance during late pregnancy. Journal of Addictive Diseases, 18 (4), 51-61.
  
  
• Joe, G.W., Simpson, D.D., et Broome, K.M. (1999). Retention and patient engagement models for different treatment modalities in DATOS. Drug and Alcohol Dependence, 57, 113-125.
  
  
• Jones, H. E., Velex, M. L., McCaul, M. E., et Svikis, D. S. (1999). Special treatment issues for women. In E. C. Strain et M. L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 251-280). Baltimore: The Johns Hopkins University Press.
  
  
• Joseph, H., Stancliff, S., et Langrod, J. (2000). Methadone maintenance treatment (MMT): A review of historical and clinical issues. The Mount Sinai Journal of Medicine 67 (5et6), 347-364.
  
  
• Kaltenbach, K., Berghella, V., et Finnegan, L. (1998). Opioid dependence during pregnancy. Effects and management. Obstetrics and Gynecology Clinics of North America, 25(1), 139-151.
  
  
• Kandall, S. R., Doberczak, T. M., Jantunen, M., et Stein, J. (1999). The methadone-maintained pregnancy. Clinics in Perinatology, 26(1), 173-183.
  
  
• Kidorf, M., King, V. L., et Brooner, R. K. (1999). Integrating psychosocial services with methadone treatment: Behaviorally contingent pharmacotherapy. In E. C. Strain et M. L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 166-195). Baltimore: The Johns Hopkins University Press.
  

• King, V. L., et Brooner, R. K. (1999). Assessment and treatment of comorbid psychiatric disorders. In E.C. Strain et M..L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 141-165). Baltimore: The Johns Hopkins University Press.
  
  
• Langendam, M. W., Van Haastrecht, H. J. A., Van Brussel, G. H. A., Reurs, H., Van Den Hoek, A. J. A. R., Coutinho, R. A., et Van Ameijden, E. J. C. (1998). Differentiation in the Amsterdam methadone dispensing circuit: Determinants of methadone dosage and site of methadone prescription. Addiction, 93(1), 61-72.
  
  
• Leavitt, S., Shinderman, M., Maxwell, S., Chin, B., et Paris, P. (2000). When "enough" is not enough: New perspectives on optimal methadone maintenance dose. The Mount Sinai Journal of Medicine, 67 (5et6), 404-411.
  
  
• Leshner, A.I. (1999). Science-based views of drug addiction and treatment. JAMA, [On-line] 282(14).
  
  
• Lindesmith Centre, The. (1997). Methadone maintenance treatment.[Brochure]. New York and San Francisco: Author.
  
  
• Longshore, D., Hsieh, S., et Anglin, M.D. (1994). Reducing HIV risk behavior among injection drug users: Effect of methadone maintenance treatment on number of sex partners. The International Journal of the Addictions, 29 (6), 741-757.
  
  
• Lowinson, J. H., Payte, J. T., Salsitz, E., Joseph, H., Marion, I. J., et Dole, V. P. (1997.) Methadone maintenance. In J. H. Lowinson, J. T. Payte, E. Salsitz, H. Joseph, I. J. Marion, et V. P. Dole (Eds.), Substance Abuse: a comprehensive text (3rd ed.., pp. 405-415). Baltimore: Williams et Wilkins.
  

• Magura, S., Nwakeze, P. C., et Demsky, S. (1998a). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93(1), 51-60.
  
  
• Magura, S., Rosenblum, A., et Rodriguez, E. M. (1998b). Changes in HIV risk behaviors among cocaine-using methadone patients. Journal of Addictive Diseases, 17(4), 71-90.
  
  
• Marsch, L. (1998). The efficacy of methadone maintenance intervention in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction, 93 (4), 515-32.
  

• Mattick, R.P., Ward, J., et Hall, W. (1998). The role of counselling and psychological therapy. In J. Ward, R..P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 265-304). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• McPhilips, M. A., Strang, J., et Barnes, T. R. E. (1998). Hair analysis. New laboratory ability to test for substance use. British Journal of Psychiatry, 173, 287-289.
  
  
• National Institute on Drug Abuse. (1995). Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author.
  
  
• National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. (1998). Effective medical treatment of opiate addiction. JAMA, 280(22), 1936-1943.
  

• Novick, D.M. (2000). The Impact of Hepatitis C Virus Infection on Methadone Maintenance Treatment. The Mount Sinai Journal of Medicine, 67 (5 and 6), 437-443.
  
  
• Ontario Ministry of Health. (1999). A Report on the Provincial Conference on Methadone Treatment. March 22-24, 1999. Toronto: Author.
  
  
• Payte, J.T. (2000). Clinical take homes. Journal of Maintenance in the Addictions, 1 (4), 113-114.
  

• Robles, E., Silverman, K., et Stitzer, M. L. (1999). Contingency management therapies. In E.C. Strain et M. L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 196-222). Baltimore: The Johns Hopkins University Press.
  
  
• Rothbard, A., Alterman, A., Rutherford, M., Liu, F., Zelinski, S., et McKay, J. (1999). Revisiting the effectiveness of methadone treatment on crime reductions in the 1990's. Journal of Substance Abuse Treatment, 16(4), 329-335.
  

• Rothon, D.A., Mathias, R.G., et Schechter, M.T.(1994). Prevalence of HIV infection in provincial prisons in British Columbia. Canadian Medical Association Journal, 151 (6),781-787.
  
  
• Rothon, D.A., Strathdee, S.A., Cook, D., et Cornelisse, P.G.A. (1997). Determinants of HIV-related high-risk behaviours among young offenders: A window of opportunity. Canadian Journal of Public Health, 88(1), 14-17.
  
  
• Salsitz, E.A., Joseph, H., Frank, B., Perez, J., Richman, B.L., Salomon, N., Kalin, M.F, et Novick, D.M. (2000). Methadone medical maintenance (MMM): Treating chronic opioid dependence in private medical practice-a summary report (1983-1998). The Mount Sinai Journal of Medicine 67 (5 et 6), 388-397.
  
  
• Santé Canada (2002a). Recension de la documentation: traitement d'entretien à la méthadone. Ottawa: Ministère des Travaux publiques et services gouvernementaux Canada.
  
  
• Santé Canada (2002b). Traitement d'entretien à la méthadone (Brochure). Ottawa: Ministère des Travaux publiques et services gouvernementaux Canada.
  
  
• Santé Canada (2001a). Meilleures pratiques - Traitement et réadaption des femmes ayant des problèmes attribuables à la consommation d'alcool et d'autres drogues. Ottawa: Ministère des Travaux publiques et services gouvernementaux Canada.
  

• Santé Canada (2001b). Meilleures pratiques: traitement et réadaptation des jeunes ayant des problèmes attribuables à la consommation d'alcool et d'autres drogues. Ottawa: Ministère des Travaux publiques et services gouvernementaux Canada.
  
  
• Santé Canada. (2000a). Comportement à risque chez les utilisateurs de drogues injectables au Canada. Actualités en épidémiologie sur le VIH/sida, actualités du Bureau du VIH/sida des MTS et de la tuberculose. Centre de prévention et de contrôle des maladies infectieuses.
  
  
• Santé Canada (2000b). Moyens de joindre les utilisateurs de drogues injectables. Document de travail. Préparer pour le Programme de prévention de soutien et de recherche concernant l'hépatite C, Direction général de la santé de la population et de la santé publique, Santé Canada. Septembre 2000 par Jamie Wieb et Bette Reimer, au nom du Centre canadien de lutte contre l'alcoolisme et les toxicomanies.
  

• Santé Canada (2000c). Ressource relative à l'hépatite C et à l'utilisation de drogues injectables au Canada. Préparer pour le Programme de prévention de soutien et de recherche concernant l'hépatite C, Direction général de la santé de la population et de la santé publique, Santé Canada. Septembre 2000 par Jamie Wieb et Bette Reimer, au nom du Centre canadien de lutte contre l'alcoolisme et les toxicomanies.
  
  
• Santé Canada (1999a). Le VIH et le sida chez les peuples autochtones du Canada. Actualités en épidémiologie sur le VIH/sida, actualités du Bureau du VIH/sida des MTS et de la tuberculose. Centre de prévention et de contrôle des maladies infectieuses.
  

• Santé Canada (1999b). Le VIH et le sida chez les utilisateurs de drogues injectables au Canada. Actualités en épidémiologie sur le VIH/sida, actualités du Bureau du VIH/sida des MTS et de la tuberculose. Centre de prévention et de contrôle des maladies infectieuses.
  
  
• Santé Canada (1999c). Meilleures pratiques - alcoolisme et toxicomanie - traitement et réadaptation. Ottawa: Ministère des Travaux publiques et services gouvernementaux Canada.
  
  
• Santé Canada (1999d). Profile - Alcoolisme et toxicomanies : traitement et réadaptation au Canada. Ministère des Travaux publiques et services gouvernementaux Canada.
  
  
• Santé Canada (1998). National consultation meeting on methadone maintenance treatment. February 19-20, 1998, Ottawa, Ontario.
  

• Santé et bien-être Canada (1992). L'utilisation des opioïdes dans le traitement de dépendance aux opioïdes. Direction générale de la protection de la santé. Santé Canada.
  
  
• Serpelloni, G., Carrieri, M.P., Rezza, G., Morganti, S., Gomma, M., et Binkin, N. (1994). Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study. AIDS Care, 6 (2), 215-220.

• Sherman, M., et McSherry, J. (1999, August 24). Q and A: Treating hepatitis C. The Medical Post, Q1-Q7.
  
  
• Single, E. (1999). The economic implications of injection drug use. In L. Chabot (Ed.), Injection drug use: Societal challenges (pp.57-68). Montreal: University of Montreal, Faculty of Continuing Education, Drug Addiction Certificate Program.
  
  
• Stitzer, M. L., et Chutuape, M. A. (1999). Other substance use disorders in methadone treatment: prevalence, consequences, detection and management. In E. C. Strain et M. L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 86-117). Baltimore: The Johns Hopkins University Press.
  

• Stoller, K. B., et Bigelow, G. E. (1999). Regulatory, cost, and policy issues. In E. C. Strain et M. L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 15-37). Baltimore: The Johns Hopkins University Press.
  

• Strain, E.C. (1999a). Beginning and ending methadone dosing: Induction and withdrawal. In E.C. Strain et M. L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 53-61). Baltimore: The Johns Hopkins University Press.
  
  
• Strain, E. C. (1999b). Methadone dose during maintenance treatment. In E.C. Strain et M.L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 62-85). Baltimore: The Johns Hopkins University Press.
  

• Strain, E. C., et Stitzer, M. L. (Eds.).(1999). Methadone treatment for opioid dependence. Baltimore: The Johns Hopkins University Press.
  
  
• Strain, E.C., et Stoller, K.B.(1999). Introduction and historical overview. In E. C. Strain et M. L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 1-13). Baltimore: The Johns Hopkins University Press.
  

• Strain, E. C., Bigelow, G. E., Liebson, I. A., et Stitzer, M. L. (1999). Moderate- vs high-dose methadone in the treatment of opioid dependence. The Journal of the American Medical Association, 281(11), 1000-5.
  

• Walsh, S. L, et Strain, E. C. (1999). The Pharmacology of methadone. In E.C. Strain et M.L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 38-51). Baltimore: The Johns Hopkins University Press.
  

• Wall, R., Rehm, J., Fischer, B., Brands, B., Gliksman, L., Stewart, J., Melved, W., et Blake, J. (2000). Social costs of untreated opioid dependence. Journal of Urban Health. 77(4); 688-722.
  
  
• Ward, J., Mattick R.P., et Hall, W. (1998a). Assessment for opioid replacement therapy. In J. Ward, R.P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 177-203). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, J., Mattick, R.P., et Hall, W. (1998b). How long is long enough? Answers to questions about the duration of methadone maintenance treatment. In J. Ward, R.P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 305-336). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, J., Mattick, R.P., et Hall, W. (1998c). Making the transition from maintenance to abstinence: Detoxification from methadone maintenance treatment. In J. Ward, R.P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 337-358). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, J., Mattick, R.P., et Hall, W. (1998d). Methadone maintenance during pregnancy. In J. Ward, R.P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 397-416). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, J., Mattick, R.P., et Hall, W. (Eds.). (1998e). Methadone maintenance treatment and other opioid replacement therapies. Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, J., Mattick, R. P., et Hall, W. (1998f). Psychiatric comorbidity among the opioid dependent . In J. Ward, R.P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 419-440). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward J., Mattick R.P., et Hall W. (1998g). The effectiveness of methadone maintenance treatment 2: HIV and infectious hepatitis. In J. Ward, R.P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 59-73). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  

• Ward, J., Mattick, R.P., et Hall, W. (1998h). The use of methadone during maintenance treatment: Pharmacology, dosage and treatment outcome. In J. Ward, R.P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 205-238). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  

• Ward, J., Mattick, R.P., et Hall, W. (1998i). The use of urinalysis during opioid replacement therapy. In J. Ward, R.P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 239-264). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  
  
• Ward, P., et Sutton, M. (1998). The effectiveness of methadone maintenance treatment 4: Cost-effectiveness. In J. Ward, R.P. Mattick, et W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 91-121). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers.
  

• Wells, E., Calsyn, D.A., et Clark, L.L.. (1996). Retention in methadone maintenance is associated with reductions in different HIV risk behaviours for women and men. American Journal of Drug and Alcohol Abuse, 22 (4), 509-521.
  
  
• Zule, W. A., et Desmond, D. P. (1998). Attitudes toward methadone maintenance: Implications for HIV prevention. Journal of Psychoactive Drugs, 30(1), 89-97.